RESPONSE STRATEGIES TO COVID-19 CASES OR OUTBREAK AND MANAGEMENT (original) (raw)
Related papers
Coronavirus: A threat to Global Public Health
Indian Journal of Community Health, 2020
Previously considered of meagre significance to the human race, coronaviruses have effectively evolved to jump the species barrier and cause widespread contagion in mankind. The SARS pandemic, the MERS situation in the middle-east and the ongoing COVID 2019 epidemic are all attributed to this evolving virus. COVID 2019 is the seventh coronavirus isolated successfully and the third beta-coronavirus that causes a fatal illness in humans; the other two beta-coronaviruses being severe acute respiratory syndrome (SARS) CoV and middle east respiratory syndrome (MERS) CoV. Having a natural reservoir in bats these viruses infect humans through an intermediate host and then rapidly adapt and mutate for human to human transmissions. Four other known alpha coronaviruses cause only common cold in humans. Although mortality rate of COVID 2019 epidemic is lower at 2.5% than the previous two CoV outbreaks, that is, 9.6% in SARS and 34.4% in MERS, but rapid transmissibility points towards a sustain...
Coronavirus pandemic- A threat to humanity
IP innovative publication pvt ltd , 2020
The world is facing another zoonotic (transmitted between animals and people) infection caused by a novel strain of coronavirus.1 This new virus was provisionally named ‘2019-nCoV’ by the World Health Organization (WHO), but now solemnly called (from 11th February 2020) as ‘severe acute respiratory syndrome coronavirus 2 (SARSCoV- 2)’ and the disease stemming due to its infection is known as coronavirus disease 2019 (COVID-19).2 This novel coronavirus came to limelight following a spate of cases of pneumonia with no obvious reasons in December 2019 from Wuhan city of China’s Hubei province having a population of eleven million.3 The virus has now outspread to several countries across the globe.4,5
Coronavirus Disease Pandemic (COVID-19): Challenges and a Global Perspective
Pathogens, 2020
The technology-driven world of the 21st century is currently confronted with a major threat to humankind, represented by the coronavirus disease (COVID-19) pandemic, caused by the severe acute respiratory syndrome, coronavirus-2 (SARS-CoV-2). As of now, COVID-19 has affected more than 6 million confirmed cases and took 0.39 million human lives. SARS-CoV-2 spreads much faster than its two ancestors, SARS-CoV and Middle East respiratory syndrome-CoV (MERS-CoV), but has low fatality rates. Our analyses speculate that the efficient replication and transmission of SARS-CoV-2 might be due to the high-density basic amino acid residues, preferably positioned in close proximity at both the furin-like cleavage sites (S1/S2 and S2’) within the spike protein. Given the high genomic similarities of SARS-CoV-2 to bat SARS-like CoVs, it is likely that bats serve as a reservoir host for its progenitor. Women and children are less susceptible to SARS-CoV-2 infection, while the elderly and people wit...
Pandemic Coronavirus Disease (COVID-19): Challenges and A Global Perspective
2020
The technology-driven world of the 21st century is currently confronted with a major threat to humankind in the form of the coronavirus disease (COVID-19) pandemic, caused by the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). As of April 22, 2020, COVID-19 has claimed 169, 006 human lives and had spread to over 200 countries with more than 2,471,136 confirmed cases. The perpetually increasing figures associated with COVID-19 are disrupting the social and economic systems globally. The losses are unmatched and significantly higher compared to those from previously encountered pathogenic infections. Previously, two CoVs (SARS-CoV and Middle East respiratory syndrome-CoV) affected the human population in 2002 and 2012 in China and Saudi Arabia, respectively. Based on genomic similarities, animal-origin CoVs, primarily those infecting bats, civet cats, and pangolins, were presumed to be the source of emerging human CoVs, including the SARS-CoV-2. The cohesive approach amo...
Novel coronavirus pandemic: A global health threat
Turkish Journal of Emergency Medicine
The world is facing one of its worst public health crises in modern history. Coronavirus 2019 (COVID-19) has shown how fragile our global preparedness for infectious diseases is. The world is a small-connected globe with short travel time between its remote parts. COVID-19 has spread globally and swiftly with major impacts on health, economy, and quality of life of communities. At this point in the time, April 9, 2020, >1,500,000 patients have been infected and >88,000 patients have died worldwide within the last 3 months. The status is evolving and the costly lessons learned over time are increasing. These lessons are global as this virus is. They involve different domains of health sciences including virology, public health, clinical, critical care, and disaster management. This review addresses our current knowledge of COVID-19 pandemic from the basic virology and transmission, through prevention, infection control, clinical management, and finally disaster management including the recovery period. This review has a multidisciplinary approach, which is needed at this time. After this difficult period passes, we have to carry the lessons we learned for the future so that we can be better prepared. One thing that has clearly emerged from this ongoing crisis is that infectious diseases have no borders and we have to work together, using the one world, one health approach, if we are to minimize the enormous impact such pandemics can cause.
COVID-19 pandemic crisis—a complete outline of SARS-CoV-2
Future Journal of Pharmaceutical Sciences, 2020
Background Coronavirus (SARS-CoV-2), the cause of COVID-19, a fatal disease emerged from Wuhan, a large city in the Chinese province of Hubei in December 2019. Main body of abstract The World Health Organization declared COVID-19 as a pandemic due to its spread to other countries inside and outside Asia. Initial confirmation of the pandemic shows patient exposure to the Huanan seafood market. Bats might be a significant host for the spread of coronaviruses via an unknown intermediate host. The human-to-human transfer has become a significant concern due to one of the significant reasons that is asymptomatic carriers or silent spreaders. No data is obtained regarding prophylactic treatment for COVID-19, although many clinical trials are underway. Conclusion The most effective weapon is prevention and precaution to avoid the spread of the pandemic. In this current review, we outline pathogenesis, diagnosis, treatment, ongoing clinical trials, prevention, and precautions. We have also ...
Indian Journal of Forensic Medicine & Toxicology, 2020
Coronavirus disease 19 (COVID-19) is a highly communicable and pathogenic viral infection caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that has developed in Wuhan, China and spread all over the world.Genomic analysis revealed that SARS-CoV-2 is phylogenetically associated with severe, acute respiratory syndrome-like (SARS-like) bat viruses, so bats could be the primary reservoir possible. The intermediate source of origin and human transfer is unknown, but the accelerated human to human transmission has been widely confirmed.Maximal precautionary steps and resources have also been put forwardby most nations to mitigate transmission and decrease mortality rates.
Emergence of the Coronavirus (SARS-CoV-2) as a Pandemic
2020
Before the emergence of severe acute respiratory syndrome (SARS) coronavirus (SARS-CoV) in 2003, only 12 other animal or human coronaviruses were known. The discovery of this virus was soon followed by the discovery of the civet and bat SARS-CoV and the human coronaviruses NL63 and HKU1. Surveillance of coronaviruses in many animal species has increased the number on the list of coronaviruses to at least 36. The explosive nature of the first SARS epidemic, the high mortality, its transient reemergence a year later, and economic disruptions led to a rush on research of the epidemiological, clinical, pathological, immunological, virological, and other basic scientific aspects of the virus and the disease. This research resulted in over 4,000 publications, only some of the most representative works of which could be reviewed in this article. The marked increase in the understanding of the virus and the disease within such a short time has allowed the development of diagnostic tests, animal models, antivirals, vaccines, and epidemiological and infection control measures, which could prove to be useful in randomized control trials if SARS should return. The findings that horseshoe bats are the natural reservoir for SARS-CoV-like virus and that civets are the amplification host highlight the importance of wildlife and biosecurity in farms and wet markets, which can serve as the source and amplification centers for emerging infections. [1]